These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1081909)

  • 21. Relationship between 4a and 4b HLA-determined specificities and C3 receptors of leukocyte membrane.
    Ferreira A; Fotino M; Nussenzweig V
    Eur J Immunol; 1976 Nov; 6(11):832-3. PubMed ID: 1087238
    [No Abstract]   [Full Text] [Related]  

  • 22. Binding of human lymphotoxin to target-cell membranes and its relation to cell-mediated cytodestruction.
    Hessinger DA; Daynes RA; Granger GA
    Proc Natl Acad Sci U S A; 1973 Nov; 70(11):3082-6. PubMed ID: 4544711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of H-2 on the ontogenesis of a spleen cell population which lacks C3 receptors and Thy-1 antigen.
    Ferreira A; Nussenzweig V
    J Immunol; 1976 Sep; 117(3):771-3. PubMed ID: 1085310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epstein-Barr virus (EBV) receptors, complement receptors, and EBV infectibility of different lymphocyte fractions of human peripheral blood. I. Complement receptor distribution and complement binding by separated lymphocyte subpopulations.
    Yefenof E; Bakacs T; Einhorn L; Ernberg I; Klein G
    Cell Immunol; 1978 Jan; 35(1):34-42. PubMed ID: 340053
    [No Abstract]   [Full Text] [Related]  

  • 25. Lymphocyte effector molecules and cell-mediated immune reactions.
    Granger GA; Daynes RA; Runge PE; Prieur AM; Jeffes EW
    Contemp Top Mol Immunol; 1975; 4():205-41. PubMed ID: 1104257
    [No Abstract]   [Full Text] [Related]  

  • 26. Lymphotoxin. A review and analysis.
    Rosenau W; Tsoukas CD
    Am J Pathol; 1976 Sep; 84(3):580-96. PubMed ID: 786035
    [No Abstract]   [Full Text] [Related]  

  • 27. [Complement receptor on human lymphocytes detected by rosette formation. Depletion of rosette forming cells (author's transl)].
    Gilbert D; Grezes F; Ropartz C
    Ann Immunol (Paris); 1974 Nov; 125(6):855-63. PubMed ID: 4549549
    [No Abstract]   [Full Text] [Related]  

  • 28. Interactions of the third component of complement (C3) with cross-linked dextran. IV. Adherence of lymphocytes to C3 coated dextran gel particles.
    Knapp W
    Z Immunitatsforsch Exp Klin Immunol; 1975 Jul; 149(5):428-39. PubMed ID: 126575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A complement C3 fragment equivalent to mammalian C3d from the common carp (Cyprinus carpio): generation in serum after activation of the alternative pathway and detection of its receptor on the lymphocyte surface.
    Nakao M; Miura C; Itoh S; Nakahara M; Okumura K; Mutsuro J; Yano T
    Fish Shellfish Immunol; 2004 Feb; 16(2):139-49. PubMed ID: 15123318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction between the third complement protein and cell surface macromolecules.
    Law SK; Levine RP
    Proc Natl Acad Sci U S A; 1977 Jul; 74(7):2701-5. PubMed ID: 268620
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Receptors for IgG and complement in human spleen lymphoid cells. Preferential binding of particulate immune complexes through complement receptors.
    Scornik JC; Drewinko B
    J Immunol; 1975 Nov; 115(5):1223-6. PubMed ID: 1176774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaction of human lymphocytes with fluid phase human C3b detected by immunofluorescence.
    Simonian S; Molenaar JL; Zeijlemaker WP; Knape JT; Bakker S; Pondman KW
    Eur J Immunol; 1976 Jan; 6(1):52-6. PubMed ID: 823035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human monocyte spreading in vitro--inducers and effects on Fc and C3 receptors.
    Douglas SD
    Cell Immunol; 1976 Feb; 21(2):344-9. PubMed ID: 1260865
    [No Abstract]   [Full Text] [Related]  

  • 34. The heterocytotoxicity of human serum. I. Activation of the alternative complement pathway by heterologous target cells.
    Eidinger D; Bello E; Mates A
    Cell Immunol; 1977 Mar; 29(1):174-86. PubMed ID: 403014
    [No Abstract]   [Full Text] [Related]  

  • 35. [Lymphocyte-dependent antibodies in the blood serum after transplantation of cadaveric kidney].
    Tsygankova ST; Korenevskaia VA; Usova SV
    Lab Delo; 1978; (3):153-7. PubMed ID: 76704
    [No Abstract]   [Full Text] [Related]  

  • 36. Isolation on discontinuous gradients of bovine albumin of a subpopulation of human lymphocytes exhibiting precursor characteristics.
    Gatien JG; Schneeberger EE; Parkman R; Merler E
    Eur J Immunol; 1975 May; 5(5):306-12. PubMed ID: 135685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human T-cell heterogeneity as delineated with a specific human thymus lymphocyte antiserum. In vitro effects on mitogen response mixed leukocyte culture, cell-mediated lymphocytotoxicity, and lymphokine production.
    Woody JN; Ahmed A; Knudsen RC; Strong DM; Sell KW
    J Clin Invest; 1975 May; 55(5):956-66. PubMed ID: 1091657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction of Fc and C3 receptors of lymphoid cells with antibodies against products of the major histocompatibility complex: association of MHC products with complement receptors.
    Schirrmacher V; Festenstein H
    Transplant Rev; 1976; 30():140-73. PubMed ID: 59971
    [No Abstract]   [Full Text] [Related]  

  • 39. No direct activation of fluid phase C3 by lymphokines.
    Kirchhoff W; Sorg C
    Z Immunitatsforsch Immunobiol; 1977 Feb; 152(5):431-7. PubMed ID: 842071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The glomerular complement receptor in immunologically mediated renal glomerular injury.
    Gelfand MC; Shin ML; Nagle RB; Green I; Frank MM
    N Engl J Med; 1976 Jul; 295(1):10-4. PubMed ID: 1272284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.